SEC Form 4 · accession 0001645627-17-000045
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 25, 2017
Accepted (ET)
Apr 27, 2017 · 1:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0729 | A | 20,366,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0729 | A | 20,367,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0729 | A | 20,368,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0729 | A | 20,369,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0729 | A | 20,370,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.072 | A | 20,371,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.072 | A | 20,372,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.069 | A | 20,373,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.0704 | A | 20,374,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.0695 | A | 20,375,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.07 | A | 20,376,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.07 | A | 20,377,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.0695 | A | 20,378,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.0692 | A | 20,379,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.07 | A | 20,380,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.07 | A | 20,381,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.07 | A | 20,382,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.07 | A | 20,383,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.0695 | A | 20,384,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.069 | A | 20,385,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.067 | A | 20,386,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.067 | A | 20,387,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.068 | A | 20,388,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.068 | A | 20,389,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.07 | A | 20,390,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.0698 | A | 20,391,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.07 | A | 20,392,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.07 | A | 20,393,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.072 | A | 20,394,949 | D | |
| Common Stock | Apr 26, 2017 | P | 1,000 | $0.072 | A | 20,395,949 | D |
Table II — derivative securities
No Table II lines on this filing.